Clinical Advanced in Early-stage ALK-positive Non-small Cell Lung Cancer Patients

Clinical Advanced in Early-stage ALK-positive Non-small Cell Lung Cancer Patients

Lung cancer is the leading cause of cancer death in China. Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases, with the majority of the cases diagnosed at the advanced stage. Molecular targeted therapy is becoming the focus attention for advanced NSCLC. Echinoderm microtubule-a...

Full description

Bibliographic Details
Main Authors: Qiongqiong GAO, Xiangli JIANG, Chun HUANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
ALK
Testing
Clinicopathological implication
Outcome
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.07

Similar Items

Similar Items